Preclinical Development Of Complement C5aR Antagonists For The Treatment Of Motor Neuron Disease
Funder
National Health and Medical Research Council
Funding Amount
$593,326.00
Summary
There is no cure for Motor Neuron Disease (MND) resulting in 2 Australian’s dying each day. Modification of the inflammation is one potential means of slowing MND. Our research team has identified a new series of potent anti-inflammatory compounds that may have potential to treat this disease. Our project will test these compounds in animal models of MND, and validate their usefulness in human MND samples. Ultimately, this work may contribute to the discovery of a new treatment for MND.
Trials of numerous agents to slow the progression of Parkinsons disease have provided ambiguous or negative results despite having good preliminary evidence for their efficacy. The most likely reason is that many nerve cells are already destroyed by the time of diagnosis. Thus effective therapies may be most (and possible only) effective when administered in the presymptomatic stages of disease. This proposal is directed at developing method to detect early presymptomatic Parkinsons disease.
Therapeutic Targeting Of Neuroinflammation To Slow The Progression Of Neurodegenerative Disease
Funder
National Health and Medical Research Council
Funding Amount
$463,652.00
Summary
My research has identified key components of our immune system, that can worsen disease in conditions such as Parkinson’s disease and motor neuron disease. I hope that exploring these components in animal models, and patients suffering from these diseases, my group can identify new therapeutic drug candidates that can be progressed in clinical trials. Ultimately, this may lead to new treatments to reduce disease burden in patients suffering from these neurodegenerative conditions.
My research focuses on understanding pathobiological mechanisms in acute and chronic neurodegenerative conditions such as stroke and Parkinson’s disease which have large burdens on the community through health care costs and on families because of the lack of effective treatments. An improved understanding of how brain cells die and of how the most abundant brain cell, the astrocyte, can be engineered to be a resource for regenerative medicine offer promise for improved clinical management.
The Role Of Neuronal Hyperactivity And Neurotrophic Factor Signalling In Synaptogenesis, Dendrogenesis And Neuron Death In Motor Neuron Disease
Funder
National Health and Medical Research Council
Funding Amount
$700,331.00
Summary
Using mice with mutant genes causing amyotrophic lateral sclerosis, we will test whether motor neuron hyper-excitability during early development causes excessive synapse and dendrite formation, ultimately leading to neuronal death. We will also test whether activity-dependent secretion of neurotrophic factors and activation of their receptors plays a role in this disease. This will show whether neuronal hyper-activity and neurotrophic factor signaling plays a causal role in this disease.
Novel Pathomechanisms And Therapeutic Targets In Neurodegenerative Diseases
Funder
National Health and Medical Research Council
Funding Amount
$340,038.00
Summary
This fellowship will provide new insight into the molecular processes underlying onset and progression of common brain conditions, including Alzheimer’s disease, frontotemporal dementia and motor neuron disease. Furthermore, new therapeutic targets for these diseases will be developed and tested in model systems, to facilitate future translation into clinical application, and to overcome the lack of treatments.
Neural Signatures Of Disease Spread And Evolution In Motor Neurodegenerative Syndromes
Funder
National Health and Medical Research Council
Funding Amount
$408,768.00
Summary
A lack of understanding of the earliest changes brought on by motor neurone disease (MND), otherwise known as amyotrophic lateral sclerosis (ALS), prevents early diagnosis and therapeutic intervention. The proposed project aims to comprehensively characterise neurological changes prior to disease onset in pre-symptomatic carriers with a known genetic mutation linked to MND using targeted neuropsychological assessments and advanced multi-modal neuroimaging to track disease progression.
My research is focused on understanding the aetiology of brain disorders. I am interested in the interaction of genetic and environmental factors in the development of these disorders. In particular, I will evaluate the validity of rodent models for schizophrenia and Alzheimer’s disease and investigate the therapeutic potential of the endocannabinoid system for both disorders and whether environmental enrichment (e.g. physical exercise) can have beneficial effects in these models.
Volitional And Non-volitional Control Of Human Balance: Normal Physiology And Changes With Ageing
Funder
National Health and Medical Research Council
Funding Amount
$383,066.00
Summary
How does the brain control balance when we stand? Our research shows that two very distinct processes operate to produce distinct postural, perceptual and cardiovascular outcomes. These experiments investigate the neurophysiology that coordinates these systems and what happens with age. The results will fundamentally change views on balance control. Balance problems are common in neurological disorders and old age. Knowing how balance works will improve diagnosis, treatment and rehabilitation.
Influence Of Cortical Stroke And Experimental Brain Stimulation On Excitability Of Human Corticobulbar Motor Projections And Swallowing Function
Funder
National Health and Medical Research Council
Funding Amount
$130,183.00
Summary
Swallowing disorders often result from damage to the brain. They have profound consequences on patient health and quality of life and result in significant medical and socioeconomic costs. This project firstly investigates how motor networks in the brain control the muscles involved in swallowing and how this control is affected by stroke. Secondly, it evaluates the potential of novel interventions to improve impaired swallowing function following stroke by reorganising motor networks.